loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing Atezolizumab in Europe. Original Data : EMA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Orifarm AS

02 1Roche Pharma (Schweiz) AG

03 3Roche Registration GmbH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 1,200 mg

Packaging : Vials 1 20ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Solution for injection

Dosage Strength : 1,875 mg

Packaging : Vials 1 15ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 840 mg

Packaging : Vials 1 14ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

04

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Atezolizumabum

Brand Name : Tecentriq

Dosage Form : Inf Konz

Dosage Strength : 1200mg/20ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 840 mg

Packaging : Vials 1 14ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 1,200 mg

Packaging : Vials 1 20ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank